Revolutionizing Inflammation Control
Amniotic Cells
Amniotic Cells
Amniotic Cells
Amniotic mesenchymal stromal cells are ethically sourced cells with strong anti-inflammatory effects, offering consistency and scalability for developing targeted cell therapies for inflammatory disease.
Inflammation
Amniotic Cells
Amniotic Cells
Inflammation occurs when the immune system responds to injury, stress, infection, or imbalance, releasing signalling molecules that drive healing, but when persistent or excessive, cause tissue damage and disease.
Mode of Action
Amniotic Cells
Mode of Action
Mesenchymal stromal cells reduce inflammation by regulating immune responses, releasing molecules that calm immune cells and support resolution of inflammation processes.
Medical Areas
Patient Population
Mode of Action
Main areas for inflammation treatments include musculoskeletal, autoimmune, gastrointestinal, respiratory, and chronic degenerative diseases, where controlling inflammation improves symptoms, slows progression, and enhances quality of life.
Patient Population
Patient Population
Patient Population
Inflammatory diseases affect hundreds of millions of patients worldwide, spanning common chronic conditions and representing a large, growing, and underserved global patient population.
Unique Technology
Patient Population
Patient Population
Amniotic mesenchymal stromal cells are uniquely valuable because they combine strong anti-inflammatory activity with consistent quality, ethical sourcing, and scalable manufacturing, reducing risk and improving commercial viability.